Search Results - "Kedar, I"

Imaging-based prostate cancer screening among BRCA mutation carriers—results from the first round of screening by Segal, N., Ber, Y., Benjaminov, O., Tamir, S., Yakimov, M., Kedar, I., Rosenbaum, E., Sela, S., Ozalvo, R., Shavit-Grievink, L., Keder, D., Baniel, J., Margel, D.

“…Male-carriers of BRCA1/2 gene mutations have an increased risk of prostate cancer (PCa) with a more aggressive phenotype. Current screening-guidelines suggest…”
Get full text

Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews by Lieberman, S., Chen-Shtoyerman, R., Levi, Z., Shkedi-Rafid, S., Zuckerman, S., Bernstein-Molho, R., Levi, G. Reznick, Shachar, S. S., Flugelman, A., Libman, V., Kedar, I., Naftaly-Nathan, S., Lagovsky, I., Peretz, T., Karminsky, N., Carmi, S., Levy-Lahad, E., Goldberg, Y.

“…Purpose BRCA1/2 founder pathogenic variants (PVs) occur in various populations, but data on the mutational spectrum in Africans are limited. We examined…”
Get full text

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations by Lewin, R., Sulkes, A., Shochat, T., Tsoref, D., Rizel, S., Liebermann, N., Hendler, D., Neiman, V., Ben-Aharon, I., Friedman, E., Paluch-Shimon, S., Margel, D., Kedar, I., Yerushalmi, R.

“…Oncotype-DX assay has never been validated for BRCA mutation carriers. This study compares the recurrence score (RS) distribution in BRCA-positive breast…”
Get full text

The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer by Levi, Z., Kariv, R., Barnes-Kedar, I., Goldberg, Y., Half, E., Morgentern, S., Eli, B., Baris, H.N., Vilkin, A., Belfer, R.G., Niv, Y., Elhasid, R., Dvir, R., Abu-Freha, N., Cohen, S.

“…Data on the clinical presentation of constitutional mismatch repair deficiency syndrome (CMMRD) is accumulating. However, as the extraintestinal manifestations…”
Get full text

Genetic features of Lynch syndrome in the Israeli population by Goldberg, Y., Barnes-Kedar, I., Lerer, I., Halpern, N., Plesser, M., Hubert, A., Kadouri, L., Goldshmidt, H., Solar, I., Strul, H., Rosner, G., Baris, H.N., Peretz, T., Levi, Z., Kariv, R.

“…Diagnosis of Lynch syndrome (LS) may be complex. Knowledge of mutation spectrum and founder mutations in specific populations facilitates the diagnostic…”
Get full text

A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer by Kedar, I., Walsh, L., Levi, G. Reznick, Lieberman, S., Shtaya, A. Abu, Nathan, S. Naftaly, Lagovsky, I., Tomashov-Matar, R., Goldenberg, M., Basel-Salmon, L., Katz, L., Aleme, O., Peretz, T. Yablonski, Hubert, A., Rothstein, D., Castellvi-Bel, S., Walsh, T., King, M. C., Pritchard, C. C., Levi, Z., Half, E., Laish, I., Goldberg, Y.

“…Lynch syndrome is an inherited cancer predisposition syndrome caused by germline defects in any of the mismatch repair (MMR) genes. Diagnosis of carriers makes…”
Get full text

Switching from Tacrolimus to Sirolimus Halts the Appearance of New Sebaceous Neoplasms in Muir‐Torre Syndrome by Levi, Z., Hazazi, R., Kedar‐Barnes, I., Hodak, E., Gal, E., Mor, E., Niv, Y., Winkler, J.

“…Little is known about the effects of immunosuppression on patients with hereditary nonpolyposis colorectal cancer (HNPCC). We describe a kidney transplant…”
Get full text

Thalidomide reduces serum C‐reactive protein and interleukin‐6 and induces response to IL‐2 in a fraction of metastatic renal cell cancer patients who failed IL‐2‐based therapy by Kedar, Igal, Mermershtain, Wilmosh, Ivgi, Hefziba

“…Interleukin‐2 (IL‐2) has some antitumor activity in patients with renal cell carcinoma. It has been noted that response to IL‐2 and prognosis may be adversely…”
Get full text

Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations by Halpern, N., Grinshpun, A., Boursi, B., Golan, T., Margalit, O., Aderka, D., Laitman, Y., Friedman, E., Hubert, A., Peretz, T., Hamburger, T., Kedar-Barnes, I., Levi, Z., Ben-Aharon, I., Goldberg, Y., Shacham-Shmueli, E.

Get full text

152P Molecular characterization by the 21-gene breast cancer (BC) Recurrence Score (RS) test of BRCA1/2 mutation carriers (mBRCA1/2) versus the general BC patient (pt) population by Yerushalmi, R., Pomerantz, A., Lewin, R., Paluch-Shimon, S., Soussan-Gutman, L., Baehner, F.L., Voet, H., Bareket-Samish, A., Kedar, I., Kaduri, L.

Get full text

Medical records hit the "intranet" by Kedar, Iris

Get full text

A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60 by Rosen, D. J. D., Kedar, I., Amiel, A., Ben-Tovim, T., Petel, Y., Kaneti, H., Tohar, M., Fejgin, M. D.

“…Objective A study was conducted to evaluate the sensitivity of combining a second trimester triple test and targeted ultrasound in order to detect Down…”
Get full text

AIDS physicians find support in the trenches by Kedar, Iris

Get full text

Malignancies in male BRCA mutation carriers – results from a prospectively screened cohort of patients enrolled to a dedicated male BRCA clinic by Margel, D, Mano, R, Benjaminov, O, Kedar, I, Ozalvo, R, Sela, S, Ber, Y, Baniel, J

Get full text

LBA22 Imaging based PCa screening among BRCA mutation carriers: Results from the first round of screening by Margel, D., Ber, Y., Segal, N., Benjaminov, O., Tamir, S., Yakimov, M., Kedar, I., Sela, S., Ozalvo, R., Shavit-Grievink, L., Kedar, D., Baniel, J., Rosenbaum, E.

Get full text

Replication asynchrony increases in women at risk for aneuploid offspring by Amiel, A, Reish, O, Gaber, E, Kedar, I, Diukman, R, Fejgin, M

“…We attempted to demonstrate a relation between a loss of replication control, centromere dysfunction, and predisposition to non-disjunction. Couples with a…”
Get full text

ARE ALL PHENOTYPICALLY-NORMAL TURNER SYNDROME FETUSES MOSAICS? by AMIEL, A., KIDRON, D., KEDAR, I., GABER, E., REISH, O., FEJGIN, M. D.

“…Cytogenetic and fluorescent in situ hybridization (FISH) studies were performed on several formalin‐fixed tissues obtained from four fetuses diagnosed at…”
Get full text

Thermochemotherapy: Synergism between Hyperthermia (42-43 degrees) and Adriamycin (or Bleomycin) in Mammalian Cell Inactivation by Hahn, George M., Braun, Jonathan, Har-Kedar, Isaac

“…The sensitivity of cells exposed in vitro to the antibiotics bleomycin or adriamycin is only mildly increased at 41 degrees over that seen at 37 degrees…”
Get full text

Fluorescent in-situ hybridization (FISH) as an aid to marker chromosome identification in prenatal diagnosis by Amiel, A., Fejgin, M., Appelman, Z., Shapiro, I., Gaber, E., Bachar, A., Zamir, R., Kedar, I., Golbus, M.

“…Five cases of supernumerary marker chromosomes were identified in prenatal diagnosis as derived from chromosomes 18, X, and Y. One unexpected finding was in a…”
Get full text

Differential Diagnosis and Management of Very Low Second Trimester Maternal Serum Unconjugated Estriol Levels, With Special Emphasis on the Diagnosis of X-Linked Ichthyosis by Zalel, Y, Kedar, I, Tepper, R, Chen, R, Drugan, A, Fejgin, M, Beyth, Y

“…Incorporation of maternal serum unconjugated estriol into the calculation of risk may increase the yield of serum screening performed during pregnancy for…”
Get full text